1041 – 1050 of 1823
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Nationwide population-based study on 30-day mortality after radical prostatectomy in Sweden
(
- Contribution to journal › Article
-
Mark
Left Ventricular Geometry Predicts Cardiovascular Outcomes Associated with Anemia Correction in CKD
(
- Contribution to journal › Article
-
Mark
Poor Compliance With Primary Nocturnal Enuresis Therapy May Contribute to Insufficient Desmopressin Response
2009) 60th Annual Meeting of the American-Academy-of-Pediatrics/International-Childrens-Continence-Societ y 182(4). p.2045-2049(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
THE P-MARK BIOBANK: A EUROPEAN MULTICENTER BIOREPOSITORY FOR PROSTATE CANCER RESEARCH
2009) 24th Annual Congress of the European Association of Urology In European Urology Supplements 8(4). p.165-165(
- Contribution to journal › Published meeting abstract
-
Mark
A wider repertoire and increased titers of carbohydrate-specific antibodies in mice rejecting adult porcine islets
2009) Joint Meeting of the International-Pancreas-and-Islet-Transplant-Association/International-Xe notransplantation-Association In Xenotransplantation 16(5). p.367-367(
- Contribution to journal › Published meeting abstract
-
Mark
Distribution and Function of Cannabinoid Receptors 1 and 2 in the Rat, Monkey and Human Bladder
(
- Contribution to journal › Article
-
Mark
Monocyte and Neutrophil Chemotactic Activity at the Site of Interstitial Inflammation in Patients on High-Flux Hemodialysis or Hemodiafiltration
(
- Contribution to journal › Article
-
Mark
THE ROLE OF HEME OXYGENASE-1 AND CARBON MONOXIDE (CO) IN REGULATION OF CHEMOTHERAPEUTIC RESPONSES IN PROSTATE CANCER
2009) 24th Annual Congress of the European Association of Urology In European Urology Supplements 8(4). p.342-342(
- Contribution to journal › Published meeting abstract
-
Mark
Natural autoantibodies against myeloperoxidase, protease 3 and glomerular basement membrane in normal healthy individuals
(
- Contribution to journal › Published meeting abstract
-
Mark
Randomized trial of rituximab vs cyclophosphamide for ANCA-associated renal vasculitis: RITUXVAS
(
- Contribution to journal › Published meeting abstract